TIGIT Therapies Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TIGIT Therapies Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TIGIT Therapies Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global TIGIT Therapies Market Perspective (2017-2028)
2.2 TIGIT Therapies Growth Trends by Region
2.2.1 TIGIT Therapies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 TIGIT Therapies Historic Market Size by Region (2017-2022)
2.2.3 TIGIT Therapies Forecasted Market Size by Region (2023-2028)
2.3 TIGIT Therapies Market Dynamics
2.3.1 TIGIT Therapies Industry Trends
2.3.2 TIGIT Therapies Market Drivers
2.3.3 TIGIT Therapies Market Challenges
2.3.4 TIGIT Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TIGIT Therapies Players by Revenue
3.1.1 Global Top TIGIT Therapies Players by Revenue (2017-2022)
3.1.2 Global TIGIT Therapies Revenue Market Share by Players (2017-2022)
3.2 Global TIGIT Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by TIGIT Therapies Revenue
3.4 Global TIGIT Therapies Market Concentration Ratio
3.4.1 Global TIGIT Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TIGIT Therapies Revenue in 2021
3.5 TIGIT Therapies Key Players Head office and Area Served
3.6 Key Players TIGIT Therapies Product Solution and Service
3.7 Date of Enter into TIGIT Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 TIGIT Therapies Breakdown Data by Type
4.1 Global TIGIT Therapies Historic Market Size by Type (2017-2022)
4.2 Global TIGIT Therapies Forecasted Market Size by Type (2023-2028)
5 TIGIT Therapies Breakdown Data by Application
5.1 Global TIGIT Therapies Historic Market Size by Application (2017-2022)
5.2 Global TIGIT Therapies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America TIGIT Therapies Market Size (2017-2028)
6.2 North America TIGIT Therapies Market Size by Country (2017-2022)
6.3 North America TIGIT Therapies Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe TIGIT Therapies Market Size (2017-2028)
7.2 Europe TIGIT Therapies Market Size by Country (2017-2022)
7.3 Europe TIGIT Therapies Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TIGIT Therapies Market Size (2017-2028)
8.2 Asia-Pacific TIGIT Therapies Market Size by Country (2017-2022)
8.3 Asia-Pacific TIGIT Therapies Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America TIGIT Therapies Market Size (2017-2028)
9.2 Latin America TIGIT Therapies Market Size by Country (2017-2022)
9.3 Latin America TIGIT Therapies Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TIGIT Therapies Market Size (2017-2028)
10.2 Middle East & Africa TIGIT Therapies Market Size by Country (2017-2022)
10.3 Middle East & Africa TIGIT Therapies Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche TIGIT Therapies Introduction
11.1.4 Roche Revenue in TIGIT Therapies Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck TIGIT Therapies Introduction
11.2.4 Merck Revenue in TIGIT Therapies Business (2017-2022)
11.2.5 Merck Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca TIGIT Therapies Introduction
11.3.4 AstraZeneca Revenue in TIGIT Therapies Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 Arcus
11.4.1 Arcus Company Detail
11.4.2 Arcus Business Overview
11.4.3 Arcus TIGIT Therapies Introduction
11.4.4 Arcus Revenue in TIGIT Therapies Business (2017-2022)
11.4.5 Arcus Recent Development
11.5 Astellas
11.5.1 Astellas Company Detail
11.5.2 Astellas Business Overview
11.5.3 Astellas TIGIT Therapies Introduction
11.5.4 Astellas Revenue in TIGIT Therapies Business (2017-2022)
11.5.5 Astellas Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Detail
11.6.2 BeiGene Business Overview
11.6.3 BeiGene TIGIT Therapies Introduction
11.6.4 BeiGene Revenue in TIGIT Therapies Business (2017-2022)
11.6.5 BeiGene Recent Development
11.7 BMS
11.7.1 BMS Company Detail
11.7.2 BMS Business Overview
11.7.3 BMS TIGIT Therapies Introduction
11.7.4 BMS Revenue in TIGIT Therapies Business (2017-2022)
11.7.5 BMS Recent Development
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Detail
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences TIGIT Therapies Introduction
11.8.4 Junshi Biosciences Revenue in TIGIT Therapies Business (2017-2022)
11.8.5 Junshi Biosciences Recent Development
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Detail
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics TIGIT Therapies Introduction
11.9.4 Innovent Biologics Revenue in TIGIT Therapies Business (2017-2022)
11.9.5 Innovent Biologics Recent Development
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Detail
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma TIGIT Therapies Introduction
11.10.4 Mereo BioPharma Revenue in TIGIT Therapies Business (2017-2022)
11.10.5 Mereo BioPharma Recent Development
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Detail
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics TIGIT Therapies Introduction
11.11.4 Seattle Genetics Revenue in TIGIT Therapies Business (2017-2022)
11.11.5 Seattle Genetics Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Detail
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine TIGIT Therapies Introduction
11.12.4 Hengrui Medicine Revenue in TIGIT Therapies Business (2017-2022)
11.12.5 Hengrui Medicine Recent Development
11.13 Compugen
11.13.1 Compugen Company Detail
11.13.2 Compugen Business Overview
11.13.3 Compugen TIGIT Therapies Introduction
11.13.4 Compugen Revenue in TIGIT Therapies Business (2017-2022)
11.13.5 Compugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global TIGIT Therapies Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global TIGIT Therapies Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global TIGIT Therapies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global TIGIT Therapies Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global TIGIT Therapies Market Share by Region (2017-2022)
Table 8. Global TIGIT Therapies Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global TIGIT Therapies Market Share by Region (2023-2028)
Table 10. TIGIT Therapies Market Trends
Table 11. TIGIT Therapies Market Drivers
Table 12. TIGIT Therapies Market Challenges
Table 13. TIGIT Therapies Market Restraints
Table 14. Global TIGIT Therapies Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global TIGIT Therapies Market Share by Players (2017-2022)
Table 16. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2021)
Table 17. Ranking of Global Top TIGIT Therapies Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by TIGIT Therapies Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TIGIT Therapies Product Solution and Service
Table 21. Date of Enter into TIGIT Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TIGIT Therapies Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global TIGIT Therapies Revenue Market Share by Type (2017-2022)
Table 25. Global TIGIT Therapies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global TIGIT Therapies Revenue Market Share by Type (2023-2028)
Table 27. Global TIGIT Therapies Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global TIGIT Therapies Revenue Market Share by Application (2017-2022)
Table 29. Global TIGIT Therapies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global TIGIT Therapies Revenue Market Share by Application (2023-2028)
Table 31. North America TIGIT Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America TIGIT Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe TIGIT Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe TIGIT Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific TIGIT Therapies Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific TIGIT Therapies Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America TIGIT Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America TIGIT Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa TIGIT Therapies Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa TIGIT Therapies Market Size by Country (2023-2028) & (US$ Million)
Table 41. Roche Company Detail
Table 42. Roche Business Overview
Table 43. Roche TIGIT Therapies Product
Table 44. Roche Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 45. Roche Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck TIGIT Therapies Product
Table 49. Merck Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca TIGIT Therapies Product
Table 54. AstraZeneca Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Arcus Company Detail
Table 57. Arcus Business Overview
Table 58. Arcus TIGIT Therapies Product
Table 59. Arcus Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 60. Arcus Recent Development
Table 61. Astellas Company Detail
Table 62. Astellas Business Overview
Table 63. Astellas TIGIT Therapies Product
Table 64. Astellas Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 65. Astellas Recent Development
Table 66. BeiGene Company Detail
Table 67. BeiGene Business Overview
Table 68. BeiGene TIGIT Therapies Product
Table 69. BeiGene Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 70. BeiGene Recent Development
Table 71. BMS Company Detail
Table 72. BMS Business Overview
Table 73. BMS TIGIT Therapies Product
Table 74. BMS Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 75. BMS Recent Development
Table 76. Junshi Biosciences Company Detail
Table 77. Junshi Biosciences Business Overview
Table 78. Junshi Biosciences TIGIT Therapies Product
Table 79. Junshi Biosciences Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 80. Junshi Biosciences Recent Development
Table 81. Innovent Biologics Company Detail
Table 82. Innovent Biologics Business Overview
Table 83. Innovent Biologics TIGIT Therapies Product
Table 84. Innovent Biologics Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 85. Innovent Biologics Recent Development
Table 86. Mereo BioPharma Company Detail
Table 87. Mereo BioPharma Business Overview
Table 88. Mereo BioPharma TIGIT Therapies Product
Table 89. Mereo BioPharma Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 90. Mereo BioPharma Recent Development
Table 91. Seattle Genetics Company Detail
Table 92. Seattle Genetics Business Overview
Table 93. Seattle Genetics TIGIT TherapiesProduct
Table 94. Seattle Genetics Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 95. Seattle Genetics Recent Development
Table 96. Hengrui Medicine Company Detail
Table 97. Hengrui Medicine Business Overview
Table 98. Hengrui Medicine TIGIT TherapiesProduct
Table 99. Hengrui Medicine Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 100. Hengrui Medicine Recent Development
Table 101. Compugen Company Detail
Table 102. Compugen Business Overview
Table 103. Compugen TIGIT TherapiesProduct
Table 104. Compugen Revenue in TIGIT Therapies Business (2017-2022) & (US$ Million)
Table 105. Compugen Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TIGIT Therapies Market Share by Type: 2021 VS 2028
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global TIGIT Therapies Market Share by Application in 2021 & 2028
Figure 5. Cell Carcinoma Case Studies
Figure 6. Solid Tumor Case Studies
Figure 7. TIGIT Therapies Report Years Considered
Figure 8. Global TIGIT Therapies Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global TIGIT Therapies Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global TIGIT Therapies Market Share by Region: 2021 VS 2028
Figure 11. Global TIGIT Therapies Market Share by Players in 2021
Figure 12. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by TIGIT Therapies Revenue in 2021
Figure 14. North America TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America TIGIT Therapies Market Share by Country (2017-2028)
Figure 16. United States TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe TIGIT Therapies Market Share by Country (2017-2028)
Figure 20. Germany TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific TIGIT Therapies Market Share by Region (2017-2028)
Figure 28. China TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America TIGIT Therapies Market Share by Country (2017-2028)
Figure 36. Mexico TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa TIGIT Therapies Market Share by Country (2017-2028)
Figure 40. Turkey TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia TIGIT Therapies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Roche Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 43. Merck Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 44. AstraZeneca Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 45. Arcus Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 46. Astellas Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 47. BeiGene Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 48. BMS Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 49. Junshi Biosciences Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 50. Innovent Biologics Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 51. Mereo BioPharma Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 52. Seattle Genetics Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 53. Hengrui Medicine Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 54. Compugen Revenue Growth Rate in TIGIT Therapies Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
